Results 101 to 110 of about 5,684 (155)

Proteomics Profiling Reveals Molecular Subtypes of Transthyretin Cardiac Amyloidosis. [PDF]

Circ Heart Fail
Osawa I, Teruya SL, Bampatsias D, Mirabal A, Maurer MS, Shimada YJ.   +5 more
europepmc   +1 more source

Phenotypic Considerations for Tafamidis Use in a Real-World Cohort of Older Patients with Transthyretin Amyloid Cardiomyopathy. [PDF]

Cardiol Ther
Fumagalli C, Cappelli F, Maurer MS, Aus dem Siepen F, Dispenzieri A, Garcia-Pavia P, Hanna M, Carlsson M, Damy T.   +8 more
europepmc   +1 more source

ACO-SWITCH: Rationale and Design of a Phase 4 Study Evaluating Serum Transthyretin in ATTR-CM After Switching from Tafamidis to Acoramidis. [PDF]

Cardiol Ther
Pfister R, Michel L, Schulze M, Vogtländer K, Ciaccia A, Merz M, Hengstenberg C.   +6 more
europepmc   +1 more source

Sex Differences in a Contemporary, Real-World Cohort of Patients with Transthyretin Amyloid Cardiomyopathy Treated with Tafamidis. [PDF]

Cardiol Ther
Fontana M, Aimo A, Grogan M, Crespo-Leiro MG, Maurer MS, Siepen FAD, Hanna M, Delgado D, Carlsson M, Damy T, Davis MK.   +10 more
europepmc   +1 more source

Tafamidis in the Contemporary Management of Transthyretin Cardiac Amyloidosis: A Systematic Review. [PDF]

J Clin Med
Nasser A, Michalczak M, Malkowski A, Zgoda WM, Michalczak J, Żądło A, Tokarek T.   +6 more
europepmc   +1 more source

Differential Effects of Tafamidis on Cardiac Remodelling in Transthyretin Amyloid Cardiomyopathy: Evidence From Contemporary Imaging Data. [PDF]

Eur J Clin Invest
Quader T, Patel K, Sindone J, Khanna S, Bhat A, Chen H, Gan G, Nerlekar N, Eshoo S, Bart N, Thomas L, Sindone A.   +11 more
europepmc   +1 more source

Clinical Factors Related to Cardiac Conduction Disturbance in Patients With Wild-Type Transthyretin Amyloid Cardiomyopathy Undergoing Tafamidis Treatment. [PDF]

Circ Rep
Hamamoto K, Kitagawa T, Okamoto D, Sada Y, Tatsugami F, Nakano Y.   +5 more
europepmc   +1 more source

Diagnosing Transthyretin Cardiac Amyloidosis in Japan: Lessons From J-COSSA on Access, Equity, and Earlier Detection. [PDF]

JACC Asia
Alexander KM, Kitakata H.
europepmc   +1 more source

Differential Transthyretin Stabilization in Patients With Wild Type and Variant Transthyretin Amyloidosis. [PDF]

JACC CardioOncol
Judge DP, Ji AX, Graef IA, Grogan M, Soman P, Cappelli F, Fontana M, Masri A, Gillmore JD, Garcia-Pavia P, Cao X, Fox JC, Sinha U.   +12 more
europepmc   +1 more source

Disease-Modifying Therapies for Transthyretin Amyloid Cardiomyopathy: Current Evidence and Emerging Strategies. [PDF]

J Clin Med Res
Kachhadia MP, Gautam A, Meadows S, Kotadiya SR, Aryal R, Ilyas H, Shaikh JD, Gill G, Shah S, Patel J, Sanghvi HA.   +10 more
europepmc   +1 more source